Order Article Reprints

Jung S-W, Lim SH, Jeon JJ, Heo Y-W, Choi MS, Hong S-P. Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center. Biomedicines. 2022; 10(5):1058. https://doi.org/10.3390/biomedicines10051058

Jung, Seung-Won, Sung Ha Lim, Jae Joon Jeon, Yeon-Woo Heo, Mi Soo Choi, and Seung-Phil Hong. 2022. "Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center" Biomedicines 10, no. 5: 1058. https://doi.org/10.3390/biomedicines10051058

Jung, S. -W., Lim, S. H., Jeon, J. J., Heo, Y. -W., Choi, M. S., & Hong, S. -P. (2022). Comparison of the Efficacy and Safety of Biologics (Secukinumab, Ustekinumab, and Guselkumab) for the Treatment of Moderate-to-Severe Psoriasis: Real-World Data from a Single Korean Center. Biomedicines, 10(5), 1058. https://doi.org/10.3390/biomedicines10051058